Available to SourceHuman Prescription DrugOncology & Specialty

Augtyro (Repotrectinib)

160 mg/1 · Capsule

By E.R. Squibb & Sons, L.L.C.

Repotrectinib · Capsule · 160 mg

NDC: 0003-4160
Route: Oral
Therapeutic class: Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor , Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]
Marketing category: NDA

Package sizes

14 CAPSULE in 1 BOTTLE (0003-4160-14)NDC 0003-4160-14Available to Order
60 CAPSULE in 1 BOTTLE (0003-4160-60)NDC 0003-4160-60Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Augtyro (Repotrectinib)

Package sizes

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)